Recently added

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

Cobo-Ibáñez, Tatiana; Castellvi, Ivan; Pros, Ana; Domínguez, Marta; Nuño-Nuño, Laura; Martínez-Barrio, Julia; ORTIZ-SANTAMARIA, VERA (BioMed Central, 2025-01-08)

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study

Victoria Ruiz, Iván; Moreno, Débora; GARCIA-CORBACHO, JAVIER; Indacochea Cusirramos, Alberto; Angelats, Laura; GONZALEZ NAVARRO, EUROPA AZUCENA; NOGUE ALIGUER, MIQUEL (Springer, 2025-02-01)

Family perspectives and experiences on implementing telehealth in pediatric palliative care: a qualitative approach

Peñarrubia San Florencio, Lucía; Godoy Junior, Carlos; Ricart, Silvia; Navarro-Vilarrubí, Sergi; Ruiz-Herguido, Cristina; Valls Esteve, Arnau; Lahuerta-Valls, Laura (Springer, 2025-04-08)

Acromegaly facial changes analysis using last generation artificial intelligence methodology: the AcroFace system

Rashwan, Hatem A.; Asensio-Wandosell, Diego; Martínez Momblan, Mª Antonia; Marques Pamies, Montserrat; Ruiz-Janer, Sabina; Gil, Joan (Springer, 2025-04-21)

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU

Gisbert, Javier Pérez; Donday, María G; Riestra Menéndez, Sabino; Benitez, Jose Manuel; Navarro-Llavat, Mercè ; Busquets, David; Serra Nilsson, Katja; Lucendo, Alfredo J; Morales Alvarado, Víctor Jair (BMJ Publishing Group, 2025-02-06)

Scientia. Department of Health Digital Information Depot

Hospital General de Granollers - HG: Recent submissions

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study

Family perspectives and experiences on implementing telehealth in pediatric palliative care: a qualitative approach

Acromegaly facial changes analysis using last generation artificial intelligence methodology: the AcroFace system

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU

Scientia. Department of Health Digital Information Depot

Hospital General de Granollers - HG: Recent submissions

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry ﻿

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study ﻿

Family perspectives and experiences on implementing telehealth in pediatric palliative care: a qualitative approach ﻿

Acromegaly facial changes analysis using last generation artificial intelligence methodology: the AcroFace system ﻿

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU ﻿

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal study

Family perspectives and experiences on implementing telehealth in pediatric palliative care: a qualitative approach

Acromegaly facial changes analysis using last generation artificial intelligence methodology: the AcroFace system

Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU